Merck & Co Inc: All Recent News

• All recent news
• Earnings news

H-P: Analysts' Upgrades, Downgrades 9:24 AM

See who made what calls. At TheStreet.com

Merck says key Fosamax lawsuit dismissed 7:40 AM

WHITEHOUSE STATION, N.J. (AP) - Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction. Associated Press

Market Report -- In Play (MRK) 11/23/2009

Merck wins summary judgment in second federal bellwether case involving FOSAMAX (alendronate sodium) Co said that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in... Briefing.com

Merck Wins Summary Judgment in Second Federal Bellwether Case... 11/23/2009

Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemingsv. Merck. Flemings is the second of three cases involving FOSAMAX (alendronate... Business Wire

Final Glance: Pharmaceuticals companies 11/23/2009

NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading:... Associated Press

Merck, SPDR Gold: Money Flow Leaders (MRK, GLD) 11/23/2009

... At Wall Street Journal

Dow Breaks Losing Streak 11/23/2009

... At Wall Street Journal

Vioxx and Heart Attack Linked in 2001 11/23/2009

... At Wall Street Journal

Vioxx risks could have been detected earlier-study 11/23/2009

... At Thomson Reuters

UPDATE 1-US lawsuit over Merck bone drug Fosamax dismissed 11/23/2009

... At Thomson Reuters

Sage Advice On Vytorin 11/23/2009

So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data is collected on a new medicine? Merck has lots of studies showing that Zetia lowers cholesterol, but there are no studies that ... At Forbes

GlaxoSmithKline pulls application for new drug use 11/23/2009

TRENTON, N.J. (AP) - British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer. Associated Press

U.S. lawsuit over Merck's Fosamax dismissed 11/23/2009

... At Thomson Reuters

The Side Effect of Developing Obesity Drugs 11/23/2009

The FDA is fickle when it comes to weight-loss drugs. At Motley Fool

($) Remember, Remember the Strength of November 11/23/2009

Being this up going into year-end puts pressure on funds to avoid selling. At TheStreet.com

More News

Market Report

News by Symbol

Today's Investing Articles

Breaking News

News by Topic

News by Industry

MSNBC News

MSN Money

Search MSN Money

Message Boards

Site Status